Antibiotic Rifaximin for Treatment of Chronic Liver Disease-Induced HE: A Longitudinal In Vivo 1H-MRS Study of Brain Metabolism on BDL Rats

Rolf Gruetter, Cristina Ramona Cudalbu Moldovan, Emmanuelle Ines Flatt, Stefanita-Octavian Mitrea
2019
Conference Papers

Source officielle

À propos
Confidentialité
Mentions légales

Graph Chatbot

Rolf Gruetter, Cristina Ramona Cudalbu Moldovan, Emmanuelle Ines Flatt, Stefanita-Octavian Mitrea
2019
Conference Papers

Source officielle

Publications associées (3)

https://infoscience.epfl.ch/entities/publication/03f01106-244c-450a-8da3-f8bccb110c69

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (3)

The Slc25a47 locus is a novel determinant of hepatic mitochondrial function implicated in liver fibrosis

Johan Auwerx, Kristina Schoonjans, Alessia Perino, Xiaoxu Li, Hao Li, Hadrien Charles Edouard Demagny, Yu Sun, Vera Monica Lemos Da Silva, Francesca Pontanari, Nadia Bresciani

Background & Aims: Transporters of the SLC25 mitochondrial carrier superfamily bridge cytoplasmic and mitochondrial metabolism by channeling metabolites across mitochondrial membranes and are pivotal for metabolic homeostasis. Despite their physiological r ...

ELSEVIER2022

Abnormal brain oxygen homeostasis in an animal model of liver disease

Cristina Ramona Cudalbu Moldovan, Dunja Simicic, Katarzyna Pierzchala

Background & Aims: Increased plasma ammonia concentration and consequent disruption of brain energy metabolism could underpin the pathogenesis of hepatic encephalopathy (HE). Brain energy homeostasis relies on effective maintenance of brain oxygenation, an ...

ELSEVIER2022

SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease

Bernard Schneider

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is considered a health epidemic with potential devastating effects on the patients and the healthcare systems. Current preclinical models of NAFLD are invariably imperfect and generally take a lon ...

2021